• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

Introduction to (R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol (CAS No. 1047665-29-1)

(R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol, with the CAS number 1047665-29-1, is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a chiral center and a functionalized aromatic ring. These properties make it a valuable candidate for various applications, particularly in the development of new therapeutic agents.

The chiral nature of (R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol is crucial for its biological activity and selectivity. Chirality, or the property of molecules that are non-superimposable on their mirror images, plays a pivotal role in drug design and development. The R enantiomer of this compound has been shown to exhibit distinct pharmacological properties compared to its S counterpart, making it an important focus in enantioselective synthesis and drug optimization.

Recent studies have highlighted the potential of (R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol in various therapeutic areas. One notable application is its use as a ligand for G protein-coupled receptors (GPCRs), which are key targets for many drugs. GPCRs are involved in numerous physiological processes, including neurotransmission, sensory perception, and immune responses. The ability of this compound to modulate GPCR activity could lead to the development of novel treatments for conditions such as neurodegenerative diseases, cardiovascular disorders, and metabolic syndromes.

In addition to its potential as a GPCR ligand, (R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol has been investigated for its antioxidant properties. Oxidative stress is a major contributor to cellular damage and is implicated in the pathogenesis of many diseases. Studies have shown that this compound can effectively scavenge free radicals and protect cells from oxidative damage, suggesting its potential as a therapeutic agent for conditions characterized by oxidative stress.

The synthesis of (R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol has been optimized using modern synthetic techniques, including asymmetric catalysis and chiral resolution methods. These approaches have enabled the efficient production of the desired enantiomer with high purity and yield. The ability to synthesize this compound on a large scale is essential for its practical application in pharmaceutical research and development.

Clinical trials are currently underway to evaluate the safety and efficacy of (R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol in various therapeutic contexts. Preliminary results have been promising, with the compound demonstrating favorable pharmacokinetic properties and low toxicity profiles. These findings suggest that it has the potential to be developed into a safe and effective therapeutic agent.

Furthermore, computational studies have provided insights into the molecular mechanisms underlying the biological activity of (R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol. Molecular dynamics simulations and docking studies have revealed that this compound interacts specifically with key residues in target proteins, leading to modulations in their activity. This information is valuable for rational drug design and optimization.

In conclusion, (R)-2-(2-(3-Aminopropyl)phenoxy)propan-1-ol (CAS No. 1047665-29-1) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features, chiral nature, and diverse biological activities make it an important focus for further investigation and development. As research continues to advance, it is likely that this compound will play a significant role in the discovery and development of new therapeutic agents for various diseases.

• 937653-39-9(3-(2-Ethoxyphenyl)-1-propanamine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)